N/A
Manufactured by RB Health (US) LLC
14,865 FDA adverse event reports analyzed
Last updated: 2026-04-14
DEXTROMETHORPHAN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by RB Health (US) LLC. The most commonly reported adverse reactions for DEXTROMETHORPHAN include DRUG INEFFECTIVE, DRUG ABUSE, TOXICITY TO VARIOUS AGENTS, OVERDOSE, DIZZINESS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DEXTROMETHORPHAN.
Out of 7,478 classified reports for DEXTROMETHORPHAN:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 14,865 FDA FAERS reports that mention DEXTROMETHORPHAN. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, DRUG ABUSE, TOXICITY TO VARIOUS AGENTS, OVERDOSE, DIZZINESS, ACCIDENTAL OVERDOSE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list RB Health (US) LLC in connection with DEXTROMETHORPHAN. Always verify the specific product and NDC with your pharmacist.